Dual antiplatelet therapy is associated with high α-tubulin acetylation in circulating platelets from coronary artery disease patients

In conclusion, our study highlights the role of elevated platelet α-tubulin K40 acetylation as a marker of platelet inhibition in response to DAPT.Clinical trial registration: https://clinicaltrials.gov - NCT03034148.PMID:37700239 | DOI:10.1080/09537104.2023.2250002

Source: Platelets - September 12, 2023 Category: Hematology Authors: Valentine Robaux Shakeel Kautbally Audrey Ginion M élanie Dechamps Sibille Lejeune Nassiba Menghoum Luc Bertrand Anne-Catherine Pouleur Sandrine Horman Christophe Beauloye Source Type: research